Status:
UNKNOWN
Immunological Profile of Solid Tumors Sample
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Collaborating Sponsors:
Innate Pharma
Conditions:
Solid Cancer
Eligibility:
All Genders
18+ years
Brief Summary
It has become clear in the recent year that the nature of the immune cells infiltrate within a tumor was essential in the control of the tumor growth. This so-called immune contexture does vary betwee...
Eligibility Criteria
Inclusion
- Sample must have had a valid written informed consent for available archival tumor samples for scientific purposes.
- Sample from patients with histologically documented cancer in target population.
Exclusion
- Samples from subject unwilling to give their informed consent;
- Unusable sample or biologically deteriorated.
Key Trial Info
Start Date :
April 6 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 6 2020
Estimated Enrollment :
1040 Patients enrolled
Trial Details
Trial ID
NCT03311100
Start Date
April 6 2017
End Date
April 6 2020
Last Update
January 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Marseille
Marseille, France, 13354